The company's purpose is to conduct research, development, manufacturing and distribution of products as well as providing services in the fields of pharmaceutical industry, biotechnology, chemistry, nutrition and related areas. The company is part of the group controlled by Lonza Group AG as the parent company. The company may engage in any type of investment and lending business, as well as enter into guarantees, it may provide direct or indirect financing to group companies or third parties, including their direct shareholders and their direct or indirect subsidiaries, and provide security for liabilities of such other companies of any kind, including by way of pledges or fiduciary transfers of the company's assets or guarantees of any kind, whether for consideration or not. Furthermore, it may operate a liquidity adjustment / concentration of net liquidity (cash pooling) with the aforementioned companies or join such a system, including periodic account settlement (zero balancing), also under conditions of default without interest, excluding the company's profit motive and assuming cluster risks. The company may establish branches and subsidiaries in Switzerland and abroad and participate in companies of any kind in Switzerland and abroad, acquire or establish such companies, buy, rent and sell real estate, acquire and exploit industrial property rights and know-how, and conduct all business and conclude contracts that are suitable to promote the company's purpose or are directly or indirectly related to it.